Ladenburg Thalmann Cuts Targacept (TRGT) to Neutral
TRGT Hot Sheet
Rating Summary:1 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Ladenburg Thalmann's Juan Sanchez downgraded shares of Targacept (NASDAQ: TRGT) from Buy to Neutral in an intraday research note Tuesday. The analyst slashed his price target on the stock from $30 to $7.50.
Investors in the stock are responding to news of a missed primary endpoint of a RENAISSANCE Phase 3 trial.
For an analyst ratings summary and ratings history on Targacept click here. For more ratings news on Targacept click here.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
Investors in the stock are responding to news of a missed primary endpoint of a RENAISSANCE Phase 3 trial.
For an analyst ratings summary and ratings history on Targacept click here. For more ratings news on Targacept click here.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
- Caris & Co. Downgrades Viacom (VIA) to Above Average
Create E-mail Alert Related Categories
DowngradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
